• How overlooking cryogenic risks could derail your fertility business | Christine Allen, CryoFuture

  • 2024/09/12
  • 再生時間: 36 分
  • ポッドキャスト

How overlooking cryogenic risks could derail your fertility business | Christine Allen, CryoFuture

  • サマリー

  • Fertility and cryogenics are rich grounds for innovation, but it’s not enough to have a good idea. What separates the successful startups from those that fizzle out? In cryogenic storage, one slip can mean the loss of invaluable reproductive material. How do new technologies protect against failures, and what steps are being taken to make storage safer than ever before?


    In this episode you’ll hear about:

    👉🏻 Advancements in Cryogenics and Fertility Treatments

    👉🏻 Risk Mitigation in Cryogenic

    👉🏻 Opportunities for Healthtech Startups in Fertility and Cryogenics


    Our guest is Christine Allen, Director of IVF laboratory operations, Scientific Advisor at CryoFuture

    Dr. Christine Allen is a certified embryologist and andrologist who has travelled the world developing and teaching leading edge vitrification and lab automation technologies, building IVF clinics and implementing new technologies as AI research, state-of-art egg banking, non-invasive PGTA and data analytics for success improvement. Christine’s research in cryopreservation, vitrification techniques and fertilization has been published in several leading industry journals and she has presented her findings at ASRM, ESHRE and American Board of Bioanalysts (ABB) among others. She has a proven track record of the direct implementation of embroyology lab management, quality control procedures, andrology testing, outside clinician consulting and is an expert in US Food and Drug Administration (FDA), Clinical Laboratory Improvement Amendments (CLIA), American Association of Bioanalysts AAB and ASRM laboratory standards. She is also fluent in English, Portuguese, French and Italian, and proficient in Dutch and Spanish, directing labs around the world in their native languages. As per her investor endeavors, Dr. Allen focus on supporting new technologies startups related to scientific breakthroughs in IVF that could lead to better safety measures and higher quality of laboratory operations.


    You can find our guest here:

    👉🏻 https://www.linkedin.com/in/christine-a-2a9b66a/

    👉🏻 https://www.fertilityconsultancy.com/

    👉🏻 https://eliteivfteam.com/


    Applover⁠ is an ISO 13485-certified Full-Stack Digital Agency from Wrocław, Poland. Founded in 2016, a team of nearly 160 experts has developed over 200 projects. Applover was recognized by the Financial Times in the 'FT 1000' ranking in 2023 and by Deloitte as a Rising Star (Fast 50 Tech) in the CEE region in 2019, and in 2020 and 2021, in the main category of the FAST 50 ranking.


    Follow and find more inspiration:

    👉🏻 https://applover.com/blog/

    👉🏻 https://www.linkedin.com/company/applover-software-house/

    続きを読む 一部表示

あらすじ・解説

Fertility and cryogenics are rich grounds for innovation, but it’s not enough to have a good idea. What separates the successful startups from those that fizzle out? In cryogenic storage, one slip can mean the loss of invaluable reproductive material. How do new technologies protect against failures, and what steps are being taken to make storage safer than ever before?


In this episode you’ll hear about:

👉🏻 Advancements in Cryogenics and Fertility Treatments

👉🏻 Risk Mitigation in Cryogenic

👉🏻 Opportunities for Healthtech Startups in Fertility and Cryogenics


Our guest is Christine Allen, Director of IVF laboratory operations, Scientific Advisor at CryoFuture

Dr. Christine Allen is a certified embryologist and andrologist who has travelled the world developing and teaching leading edge vitrification and lab automation technologies, building IVF clinics and implementing new technologies as AI research, state-of-art egg banking, non-invasive PGTA and data analytics for success improvement. Christine’s research in cryopreservation, vitrification techniques and fertilization has been published in several leading industry journals and she has presented her findings at ASRM, ESHRE and American Board of Bioanalysts (ABB) among others. She has a proven track record of the direct implementation of embroyology lab management, quality control procedures, andrology testing, outside clinician consulting and is an expert in US Food and Drug Administration (FDA), Clinical Laboratory Improvement Amendments (CLIA), American Association of Bioanalysts AAB and ASRM laboratory standards. She is also fluent in English, Portuguese, French and Italian, and proficient in Dutch and Spanish, directing labs around the world in their native languages. As per her investor endeavors, Dr. Allen focus on supporting new technologies startups related to scientific breakthroughs in IVF that could lead to better safety measures and higher quality of laboratory operations.


You can find our guest here:

👉🏻 https://www.linkedin.com/in/christine-a-2a9b66a/

👉🏻 https://www.fertilityconsultancy.com/

👉🏻 https://eliteivfteam.com/


Applover⁠ is an ISO 13485-certified Full-Stack Digital Agency from Wrocław, Poland. Founded in 2016, a team of nearly 160 experts has developed over 200 projects. Applover was recognized by the Financial Times in the 'FT 1000' ranking in 2023 and by Deloitte as a Rising Star (Fast 50 Tech) in the CEE region in 2019, and in 2020 and 2021, in the main category of the FAST 50 ranking.


Follow and find more inspiration:

👉🏻 https://applover.com/blog/

👉🏻 https://www.linkedin.com/company/applover-software-house/

How overlooking cryogenic risks could derail your fertility business | Christine Allen, CryoFutureに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。